💨 Abstract

Singapore-based biotech company, Engine Biosciences, partners with Experimental Drug Development Centre (EDDC) to develop precision therapeutics for common cancer types, including breast, liver, kidney, and prostate cancers. The collaboration aims to create first-in-class treatments using Engine's NetMAPPR platform and EDDC's drug discovery expertise.

Courtesy: theprint.in